VYNE - VYNE Therapeutics EPS misses by $0.04 misses on revenue November, 10 2021 07:36 AM VYNE Therapeutics Inc Com VYNE Therapeutics (NASDAQ:VYNE): Q3 Non-GAAP EPS of -$0.36 misses by $0.04; GAAP EPS of -$0.41 misses by $0.09. Revenue of $4.09M (+25.1% Y/Y) misses by $0.67M. Shares -0.74% PM. Press Release For further details see: VYNE Therapeutics EPS misses by $0.04, misses on revenue